Status:
COMPLETED
Distribution, Pharmacokinetics and Extent of Sensory Blockade in ESP Blocks
Lead Sponsor:
Milton S. Hershey Medical Center
Conditions:
Distribution of Ropivacaine in Erector Spinae Plane Block
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The primary objectives of this study are to define the extent of dermatomal anesthesia and anatomical spread of injectate (as defined by MRI imaging) that is provided by an ESP block at the T5 level, ...
Eligibility Criteria
Inclusion
- Healthy adults aged 18 to 60 inclusive
- Weight between 60 and 100 kg inclusive
- Height 160 to190 cm inclusive
Exclusion
- Pregnant females
- Chronic medical condition requiring medication
- History of previous major spinal, abdominal or thoracic surgery
- Congenital abnormalities of the spine, back, thorax or abdomen
- History of major trauma to the thorax or abdomen;
- Allergy to ropivacaine or other amide local anesthetics
- The presence of any metallic implant in their body
- Any contraindication to magnetic resonance imaging as determined by completion of a standard questionnaire administered to all patients undergoing magnetic resonance imaging.
- Allergy to Gadolinium radiological contrast agent.
Key Trial Info
Start Date :
July 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03476642
Start Date
July 2 2019
End Date
March 31 2024
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Milton S.Hershey Medical center
Hershey, Pennsylvania, United States, 17033